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Lipid-laden macrophages are a hallmark of atherosclerotic lesions (1). Over
the last several years the mechanisms responsible for lipid accumulation in
macrophages have been intensively studied. Macrophages possess receptors for
low density lipoproteins (LDL), but exposure ofmacrophages to high concentra-
tions of LDL does not result in lipid accumulation, due to normal homeostatic
mechanisms (2). In contrast to normal LDL, chemically modified LDL is taken
up by specific receptors (scavenger receptors) and causes massive cholesteryl
ester accumulation in macrophages (2). Also, massive cholesteryl ester and/or
triglyceride accumulation occurs when macrophages are exposed to a variety of
different triglyceride-rich lipoproteins (2). Besides the receptor-mediated uptake
of lipoproteins, macrophages can accumulate lipids through the actions of the
secreted enzyme lipoprotein lipase (LPL) (3). A significant portion of the lipid
accumulating in macrophages followingexposure totriglyceride-rich lipoproteins
appears to be due to LPL (4).
Macrophages exist in a variety of functional states in vivo, ranging from
unstimulated resident cells, to inflammatory cells, to fully activated cells. The
state ofactivation of macrophages can be characterized bya number ofbiochem-
ical markers (5). Ofthe secretory products affected by activation, it is interesting
that the secretion ofapolipoprotein E by macrophages is markedly suppressed in
cells activated by endotoxin, pyran copolymer, Corynebacterium parvum or Bacil-
lus Calmette-Guerin (6, 7). The present studies were undertaken to examine the
effects of activation on the ability of macrophages to secrete LPL.
Materials and Methods
BriefDefinitive Report
Mouse Peritoneal Macrophage Collection and Cell Culture. Mouse peritoneal macro-
phages were obtained in different states of activation as follows. Resident unstimulated
macrophages were obtained from Swiss-Webster mice by peritoneal lavage with 10 ml of
PBS. Inflammatory macrophages were obtained from mice that had been injected 1-3 d
previously with 2 ml ofthioglycolate medium (Difco Laboratories, Detroit, MI). Primed
macrophages were obtained by injection of 100 gg of pyran copolymer (a gift of R. A.
Corrano and Adria Laboratories, Plain City, OH) 5 d before the mice were killed (8).
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FIGURE 1 .
￿
LPL secretion by macrophages at different states of activation. Mouse resident
peritoneal macrophages and macrophages elicited by thioglycolate, pyran copolymer, and C.
parvum were obtained as described in Materials and Methods. Secreted LPL was measured
after a 6-h incubation of the cells in DMEM/BSA.
Fully activated macrophages were obtained by injection of700 F,g ofC. parvum (Burroughs
Wellcome Co., Research Triangle Park, NC) 7 d before harvest (8). The peritoneal
exudative cells were plated and then washed 2 h later to remove the nonattached cells.
>99% of the attached cells in each experimental group were macrophages as judged by
light microscopy and phagocytosis of latex particles or antibody-coated RBCs. LPL activity
was assayed either immediately or on the following day (similar results were obtained).
The cells were maintained in DMEM with 10% FCS for up to 1 wk. TAI adipocytes (a
kind gift of G. Ringold, Stanford Univ.) were plated in Basal Medium Eagle containing
10% FCS. When the cells reached confluence, they were treated with 12.5 mM indo-
methacin to induce lipid storage and terminal differentiation to adipocytes.
Lipoprotein Lipase Assay.
￿
Secretion of LPL was measured by incubating the macro-
phages for 6 h with 1 ml of DMEM containing 0.5% fatty acid-free BSA (Armour
Pharmaceutical, Kankakee, IL). 5 min before the end of the incubation, 1 U of heparin
(Elkins-Sinn, Cherry Hill, NJ) was added to each well to release the membrane-bound
enzyme. Aliquots of medium were then immediately assayed for LPL activity by incubation
at 37 ° C with a phospholipid-stabilized emulsion of [sH]triolein containing final concen-
trations of 2.5 mM triolein, 2.4% BSA, and 0.2 M Tris, pH 8 .5, 0.1 M NaCl, and 8%
heated horse serum in a final volume of 0.25 ml. The assay was stopped by adding 3.2 ml
of heptane/methanol/chloroform (180:250:230), containing 20 tag/ml oleic acid, followed
by 1 ml of 0.1 M sodium borate/carbonate, pH 10.5 . After the tubes were vortexed and
centrifuged, the supernatants were counted in a Beckman scintillation counter (9). Activity
is expressed as nanoequivalents of free fatty acids released per hour per milligram of cell
protein.
Inhibition of LPL Secretion.
￿
After washing with DMEM, thioglycolate-elicited macro-
phages were incubated overnight in control DMEM/FCS, or in DMEM/FCS that had
been conditioned by C. parvum-activated macrophages for 48 h, or in DMEM/FCS
containing tumor necrosis factor (TNF) (a gift of T. White and Cetus Corp., Emeryville,
CA). On the following day, the media were removed, the cells were washed with
DMEM/BSA, and then incubated for 6 h in DMEM/BSA. After the addition of 1 U/ml
heparin for 5 min, the amount of LPL secreted into the media was assayed as described
above.
LPL Secretion by Macrophages in Different States ofActivation.
￿
Fig. 1 shows the
amounts of LPL activity secreted by the various macrophages. As reported1364
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FIGURE 2.
￿
Effect of conditioned media on LPL secretion by inflammatory macrophages.
Afterwashingthem with DMEM,thioglycolate-elicited macrophages were incubatedovernight
in control DMEM/FCS or DMEM/FCS that had been conditioned by C. parvum-activated
macrophages for 48 h. On thefollowingday, the media were removed; the cellswere washed
with DMEM/BSA, and the amount of LPL secreted into themediaover 6 h was assessed.
previously (3), resident macrophages secrete significant amounts of LPL . LPL
secretion was increased 20-40% in inflammatory macrophages elicited with
thioglycolate and in macrophages primed with pyran copolymer. In contrast,
macrophages activated with C. parvum secreted <10% of the LPL activity
observed in resident cells. When cultured for up to 7 d, C. parvum-elicited
macrophages continued to secrete only low levels of LPL, while resident, thio-
glycolate-elicited, and pyran copolymer-elicited macrophages maintained or
increased their LPL secretion during this time (data not shown).
Inhibition of LPL Secretion by Conditioned Medium from Activated Macro-
phages. Because activated macrophages secrete a number of cytokines, which
act as immunoregulators, the possibility that activated macrophages displaying
low LPL secretion could modulate LPL secretion by other macrophages was
investigated. Macrophages elicited by thioglycolate were exposed overnight to
conditioned medium from C. parvum-elicited macrophages. The thioglycolate-
elicited macrophages were then washed, fresh medium was added, and LPL
secretion was assessed . Fig. 2 shows that conditioned medium from C. parvum-
elicited macrophages caused an 80% inhibition of LPL secretion by thioglycolate-
elicited macrophages. This inhibition of LPL secretion could be observed after
30 min of exposure of inflammatory macrophages to conditioned media from C.
parvum-elicited macrophages ; maximal inhibition was seen after 6-12 h of
exposure (Fig. 3A). The ability of conditioned media from C. parvum-elicited
macrophages to inhibit LPL secretion by inflammatory macrophages was dose
dependent (Fig. 3B). Half-maximal inhibition of LPL secretion was observed
with 1 % (vol/vol) conditioned medium.
LPL Inhibitory Factor and TNF.
￿
To determine whether the factor(s) that is
secreted by C. parvum-activated macrophages and which regulates LPL secretion
by macrophages was TNF/cachectin, the effects of recombinant DNA-derived
TNF were compared to the effects of conditioned medium from C. parvum-
elicited macrophages for their abilities to influence LPL secretion by inflamma-
tory macrophages and by the stable adipogenic cell line TAI (Table 1). In
macrophages, TNF had no effect on LPL secretion, while conditioned medium100 .
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￿
Time course (A) and dose response (B) of inhibition of LPL secretion by condi-
tioned medium. Thioglycolate-elicited macrophages were incubated for various times (A) or
with varying amounts(B) of DMEM/FCS that hadbeen conditioned by C. patvum-activated
macrophages for 48 h. After the incubation, the cells were washed with DMEM/BSA, and the
amount of LPL secreted into the media over 6 h wasdetermined.
TABLE I
Regulation ofLPLSecretion in Macrophages and Adipocytes
Inflammatory
Treatment macrophages
Discussion
LPL secretion by:
TA1 adipocytes
Thioglycolate-elicited macrophages and TAI adipocytes were incubated for 18 h
with conditioned media from C. paroum-activated macrophages or with 100 ng/ml
rTNF. After incubation, the cells were washed with DMEM/BSA and incubated
with DMEM/BSA for 6 h. After the addition of I U/ml heparin for 5 min, the
amount of LPL secreted into the media was assayed in triplicate dishes.
* LPL activity is expressed as nanoequivalents of free fatty acids released per micro-
gram ofcell protein. Results represent the mean tSD.
B
1365
from C. parvum-activated cells caused a 65% inhibition. In contradistinction,
TNF inhibited LPL secretion by TAI adipocytes by >90%, while conditioned
medium from C. parvum-elicited macrophages decreased LPL secretion by 25% .
In other experiments, IL-2 and IFN (a and ,Q) were found to have no effects on
macrophage LPL secretion (data not shown).
Preliminary Characterization of LPL Inhibitory Factor.
￿
Dialysis of the condi-
tioned medium against DMEM with a 4,000 M'cutoff dialysis membrane at 4°C
for 12 h resulted in almost no loss of the LPL-inhibitory effect. Heat treatment
of the conditioned medium at 60'C for 30 min resulted in only a slight decrease
in LPL inhibition, but when the conditioned medium was heated at 100 * C for
3 min, the LPL-inhibitory effect of the medium was lost completely.
Macrophages obtained from several different species (mouse, rabbit, and
human monocyte-derived) have been found (3) to secrete LPL . Although the
secretion of LPL by macrophages probably has little impact on overall lipoprotein
LPL activity* Percent of
control
LPLactivity Percent of
control
Control 0.63 ±0.03 100 0.62 ± 0.08 100
Conditioned medium 0.22 t 0.04 35 0.47 t0.02 76
TNF 0.62 t0.01 98 0.06 f0.01 101366
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metabolism, it has an important function in the catabolism of triglyceride-rich
lipoproteins by macrophages. LPL contributes to the accumulation of lipids in
macrophages from triglyceride-rich lipoproteins by at least two mechanisms .
First, the triglycerides in lipoproteins are hydrolyzed by LPL to free fatty acids,
which are then taken up and reesterified into cellular triglyceride (4). Second,
followingthe hydrolysis oflipoprotein triglyceride by LPL, the remnant particles
formed are avidly taken up by macrophages via receptor-mediated processes (4).
While a physiological role of LPL in lipid and lipoprotein metabolism by
macrophages has been defined, little information is available concerning the
regulation of LPL secretion by macrophages. In this regard, our experiments
show that the secretion of LPL by macrophages is dramatically influenced by the
state ofactivation ofthe cell. Macrophages that had been elicited by thioglycolate
or pyran copolymer secreted greater amounts of LPL than resident (unstimu-
lated) macrophages. In contrast, macrophages elicited by C. parvum secreted
little, if any, LPL. The low levels of LPL found in the media of C. parvum-
elicited macrophages were not due to a block in the secretion of LPL, because
no intracellular LPL could be detected (data not shown).
Other researchers (10) have previously reported that macrophages that had
been treated with endotoxin orelicited by C. parvum or BacillusCalmette-Guerin
secrete a factor that inhibits LPL secretion by adipocytes. This factor has been
purified and identified as TNF/cachectin (11). In our experiments, conditioned
medium from macrophages elicited by C. parvum inhibited LPL secretion by
inflammatory macrophages in a time- and dose-dependent fashion. This factor
was clearly not TNF, since pure rTNF had no effect on LPL secretion by
macrophages but caused almost complete inhibition ofLPL secretion by cultured
adipocytes. Therefore, these findings support the notion that C. parvum-acti-
vated macrophages secrete a mediator, distinct from TNF, that is capable of
regulating theability ofsurroundingmacrophagestosecrete LPL. In preliminary
experiments, this mediator appears to be thermolabile and to have a M. >4,000 .
In addition to the changes in the secretion of LPL described in this paper,
activation of macrophages has been reported (6, 7, 12) to cause other alterations
in macrophage lipid and lipoprotein metabolism. Conditioned medium from
activated lymphocytes has been reported (12) to suppress the expression of both
LDLandscavenger receptor activities inhuman monocyte-derived macrophages.
Additionally, the synthesis and secretion of significant quantities of apolipopro-
tein E have been noted in resident and thioglycolate-elicited macrophages, but
markedly inhibited in activated macrophages obtained from mice treated with
pyran copolymer or C. parvum (7). Since LPL secretion is increased in pyran
copolymer-elicited macrophages, these findings suggest that the secretion of
LPL and apolipoprotein E are not coordinated during sequential activation .
These results highlight the diverse effects of activation in lipid and lipoprotein
metabolism. Furthermore, many of the changes in lipid metabolism may be
caused by mediators secreted by activated macrophages.
Summary
Lipoprotein lipase (LPL) activity wasmeasured in the mediaofcultured mouse
peritoneal macrophages that were isolated after the intraperitoneal injection ofBEHR AND KRAEMER
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inflammatory agents in order to yield a variety of states of activation. Fully
activated macrophages obtained from Corynebacterium parvum-injected mice
secreted very low levels of LPL when compared to unstimulated macrophages,
while inflammatory and primed macrophages had increased LPL secretion.
When inflammatory macrophages were incubated with conditioned medium
obtained from fully activated macrophages, LPL secretion decreased in a time-
and dose-dependent fashion. The factor(s) secreted by fully activated macro-
phages that inhibited LPL secretion was shown to be thermolabile and distinct
from tumor necrosis factor. These results demonstrate that activation dramati-
cally alters macrophage LPL secretion.
We thank A. R. Hoffman for helpful discussions and J. Kohl for preparing the manuscript.
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